Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C

Journal of Hepatology

Volumn 57, Issue 3, 2012, Pages 492-498

  Stättermayer, Albert Friedrich ^a   Rutter, Karoline ^a   Beinhardt, Sandra ^a   Scherzer, Thomas Matthias ^a   Stadlmayr, Andreas ^a   Hofer, Harald ^a   Wrba, Fritz ^a   Steindl Munda, Petra ^a   Krebs, Michael ^a   Datz, Christian ^a   Trauner, Michael ^a   Ferenci, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chronic hepatitis C; IL28B; Insulin resistance; PNPLA3

Indexed keywords

ASPARTATE AMINOTRANSFERASE; HEMOGLOBIN A1C; INTERLEUKIN 28B; TRIACYLGLYCEROL;

ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; FATTY LIVER; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HEPATITIS C; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ALLELES; BODY MASS INDEX; CONFIDENCE INTERVALS; FATTY LIVER; FEMALE; GENOTYPE; HEPATITIS C, CHRONIC; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; INTERLEUKINS; LIPASE; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84865144054     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.04.036     Document Type: Article

References (48)

1. M.E. Allison, T. Wreghitt, C.R. Palmer, and G.J. Alexander Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population J Hepatol 21 1994 1135 1139
2. D.L. White, V. Ratziu, and H.B. El-Serag Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis J Hepatol 49 2008 831 844
3. I.H. Cua, J.M. Hui, J.G. Kench, and J. George Genotype-specific interactions of insulin resistance, steatosis and fibrosis in chronic hepatitis C Hepatology 48 2008 723 731
4. E. Bugianesi, G. Marchesini, E. Gentilcore, I.H. Cua, E. Vanni, and M. Rizzetto Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis Hepatology 44 2006 1648 1655 (Pubitemid 44953669)
5. G. Nkontchou, J.P. Bastard, M. Ziol, M. Aout, E. Cosson, and N. Ganne-Carrie Insulin resistance, serum leptin and adiponectin levels and outcomes of viral hepatitis C cirrhosis J Hepatol 53 2010 827 833
6. K.L. Milner, D. van der Poorten, M. Trenelli, A.B. Jenkins, A. Xu, and G. Smythe Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance Gastroenterology 138 2010 932 941
7. E. Vanni, M.L. Abate, E. Gentilcore, I. Hickman, R. Gambino, and M. Cassader Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C Hepatology 50 2009 697 706
8. R. Moucari, N. Forestier, D. Larrey, D. Guyader, P. Couzigou, and Y. Benhamou Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C Gut 59 2010 1694 1698
9. M. Romero-Gomez, M. Del Mar Viloria, R.J. Andrade, J. Salmeron, M. Diago, and C.M. Fernandez-Rodriguez Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients Gastroenterology 128 2005 636 641 (Pubitemid 40585366)
10. R. Moucari, T. Asselah, D. Cazals-Hatem, H. Voitot, N. Boyer, and M.P. Ripault Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level and liver fibrosis Gastroenterology 134 2008 416 423 (Pubitemid 351181308)
11. V. Pazienza, S. Clément, P. Pugnale, S. Conzelman, M. Foti, and A. Mangia The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms Hepatology 45 2007 1164 1171 (Pubitemid 46775778)
12. T. Kawaguchi, T. Yoshida, M. Harada, T. Hisamoto, Y. Nagao, and T. Ide Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3 Am J Pathol 165 2004 1499 1508 (Pubitemid 39435150)
13. S. Aytug, D. Reich, L.E. Sapiro, D. Bernstein, and N. Begum Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes Hapatology 38 2003 1384 1392 (Pubitemid 37466964)
14. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and T.J. Urban Genetic variation in IL28B predicts hepatitis C treatment induced viral clearance Nature 461 2009 399 401
15. A.F. Stättermayer, R. Stauber, H. Hofer, K. Rutter, S. Beinhardt, and T.M. Scherzer Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis C Clin Gastroenterol Hepatol 4 2011 344 350
16. J.H. Li, X.Q. Lao, H.L. Tillmann, J. Rowell, K. Patel, and A. Thompson Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection Hepatology 51 2010 1904 1911
17. H. Hofer, H.C. Bankl, F. Wrba, P. Steindl-Munda, M. Peck-Radosavljevic, and C. Österreicher Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a Am J Gastroenterol 97 2002 2880 2885 (Pubitemid 35265443)
18. G. Leandro, A. Mangia, J. Hui, P. Fabris, L. Rubbia-Brandt, and G. Colloredo Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data Gastroenterology 130 2006 1636 1642
19. L. Valenti, M.G. Rumi, E. Galmozzi, A. Aghemo, B. Del Menico, and S. De Nicola Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis and liver damage in chronic hepatitis C Hepatology 53 2011 791 799
20. E. Trépo, P. Pradat, A. Potthoff, Y. Momozawa, E. Quertinmont, and T. Gustot Impact of patatin-like phospholipase-3 (rs739409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C Hepatology 54 2011 60 69
21. F. Stickel, S. Buch, K. Lau, H.M. Zu Schwabedissen, T. Berg, and M. Ridinger Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians Hepatology 53 2011 86 95
22. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, and L.A. Pennacchio Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
23. T. Cai, J.F. Dufour, B. Muellhaupt, T. Gerlach, M. Heim, and D. Moradpour Viral genotype-specific role of PNPLA3, PPARG, MTTP and IL28B in hepatitis C virus-associated steatosis J Hepatol 55 2011 529 535
24. H.L. Tillmann, K. Patel, A.J. Muir, C.D. Guy, J.H. Li, and X.Q. Lao Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C J Hepatol 55 2011 1195 1200
25. L. Valenti, A. Aghemo, and A.F. Stättermayer Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients J Hepatol 2012 [Epub, January 8]
26. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group Hepatology 24 1996 289 293 (Pubitemid 26260021)
27. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474 (Pubitemid 29420675)
28. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model of assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 1011 1018
29. J.F. Huang, M.L. Yu, C.F. Huang, S.H. Juo, and C.Y. Dai The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy Liver Int 2012 10.1111/j.1478-3231.2012. 02771.x [Epub ahead of print, February 22]
30. Serfaty L, Forns X, Goeser T, Ferenci P, Nevens F, Carosi G, et al. Insulin resistance and response to telaprevir plus peginterferon alfa and ribavirin in treatment-naïve, genotype 1 HCV patients. Gut 2012, Mar 2 [Epub ahead of print].
31. M. Eslam, M.A. Khattab, and S.A. Harrison Insulin resistance and hepatitis C: an evolving story Gut 60 2011 1139 1151
32. M.W. Douglas, and J. George Molecular mechanisms of insulin resistance in chronic hepatitis C World J Gastroenterol 15 2009 4356 4364
33. P. Sheppard, W. Kindsvogel, W. Xu, K. Henderson, S. Schlutsmeyer, and T.E. Whitmore IL-28, IL-29 and their class II cytokine receptor IL-28R Nat Immunol 4 2003 63 68 (Pubitemid 36104710)
34. S.V. Kotenko, G. Gallagher, V.V. Baurin, A. Lewis-Antes, M. Shen, and N.K. Shah IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex Nat Immunol 4 2003 69 77 (Pubitemid 36109115)
35. M. Honda, A. Sakai, T. Yamashita, Y. Nakamoto, E. Mizukoshi, and Y. Sakai Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C Gastroenterology 139 2010 499 509
36. T.J. Urban, A.J. Thompson, S.S. Bradrick, J. Fellay, D. Schuppan, and K.D. Cronin IL28B genotype is associated with different expression of intrahepatic interferon stimulated genes in patients with chronic hepatitis C Hepatology 52 2010 1888 1896
37. L. Franceschini, S. Realdon, M. Marcolongo, S. Mirandola, G. Bortoletto, and A. Alberti Reciprocal interference between insulin and interferon-alpha signaling in hepatic cells: a vicious circle of clinical significance? Hepatology 54 2011 484 494
38. M. Romero-Gómez Insulin resistance and sustained virological response in hepatitis C: from bench to bedside Liver Int 31 2011 1 3
39. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 214 223
40. M.A. Abdul-Ghani, M. Matsuda, and R.A. DeFronzo Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects Diabet Med 25 2008 1289 1294
41. T.M. Wallace, and D.R. Matthews The assessment of insulin resistance in man Diabet Med 19 2002 527 534 (Pubitemid 35300672)
42. W.C. Duckworth Insulin degradation: mechanisms, products, and significance Endocr Rev 9 1988 319 345
43. Patel K, Lucas J, Thompson JW, Moseley MA, Uzarski D, et al. High predictive accuracy of an unbiased proteomic profile to predict sustained virologic response in genotype 1 chronic hepatitis C patients. Hepatology 2011; 53: 1809-1818.
44. D.D. Cyr, J.E. Lucas, J.W. Thompson, K. Patel, and P.J. Clark Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C PLoS ONE 6 2011 e21854 10.1371/journal.pone.0021854
45. S. He, C. McPhaul, J.Z. Li, R. Garuti, L. Kinch, and N.V. Grishin A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis J Biol Chem 285 2010 6706 6715
46. Y. Huang, S. He, J.Z. Li, Y.K. Seo, T.F. Osborne, and J.C. Cohen A feed-forward loop amplifies nutritional regulation of PNPLA3 Proc Natl Acad Sci USA 107 2010 7892 7897
47. E. Herker, C. Harris, C. Hernandez, A. Carpentier, K. Kaehlcke, and A.R. Rosenberg Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1 Nat Med 16 2010 1295 1298
48. A.M. El Badry, S. Breitenstein, W. Jochum, K. Washington, V. Paradis, and L. Rubbia-Brandt Assessment of hepatic steatosis by expert pathologists Ann Surg 250 2009 691 697